SPIROXIS

Pharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills, tablets, capsules, caplets, and liquid drops sachets for the treatment of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for use within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for treating and preventing pulmonary fibrosis, namely, idiopathic pulmonary fibrosis; pharmaceutical preparations for use in treating diffuse systemic sclerosis with lung manifestations; pharmaceutical preparations for treating infectious lung diseases; pharmaceutical preparations for treatment and prevention of covid-19